跳轉至內容
Merck
  • Common ocular effects reported to a poison control center after systemic absorption of drugs in therapeutic and toxic doses.

Common ocular effects reported to a poison control center after systemic absorption of drugs in therapeutic and toxic doses.

Current opinion in ophthalmology (2014-09-17)
Ann Slattery, Erica Liebelt, LaDonna A Gaines
摘要

Ocular effects resulting from medications assist toxicologists in determining substances involved when treating a poisoned patient. The intention of this review is to discuss the most common ocular effects, the medications that cause them, and the mechanisms by which they occur. According to National Poison Data System, the most common reported ocular effects following a drug ingestion/injection/inhalation are mydriasis, miosis, and nystagmus. The most common drug/drug classes reported to a regional poison control center causing these ocular effects include the following: first, mydriasis - amphetamines and diphenhydramine; second, miosis - clonidine and opioids; third, nystagmus - dextromethorphan. However, many other drugs/substances can cause these effects along with other systemic effects. Ocular findings are a pertinent component of any patient assessment involving therapeutic and/or toxic exposure to medications and other substances.

材料
產品編號
品牌
產品描述

Supelco
右美沙芬 氢溴酸盐 一水合物, certified reference material, pharmaceutical secondary standard
Sigma-Aldrich
右美沙芬 氢溴酸盐 一水合物, ≥99% (TLC)
USP
右美沙芬 氢溴酸盐, United States Pharmacopeia (USP) Reference Standard
Supelco
可乐定 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
右美沙芬 氢溴酸盐, meets USP testing specifications
右美沙芬 氢溴酸盐, European Pharmacopoeia (EP) Reference Standard